Petros Pharmaceuticals, Inc.
Petros Pharmaceuticals, Inc.（PTPI）内幕交易
基于 SEC Form 4 的买入/卖出笔数、买卖比与情绪标签；可在本季度与近12个月之间切换；下方为季度图与交易明细。
SEC EDGAR · FMP · PTPI · 截至 2026年6月9日
活动摘要
买入笔数
0
P-Purchase only
卖出笔数
0
近12个月
买卖比
0.00
Buy/Sell (by trades)
整体情绪
Petros Pharmaceuticals, Inc.内部人在过去近12个月买卖活动混合。
▸ 数据来源：SEC EDGAR · Form 3 & 4 · 买入仅计P-Purchase · 卖出仅计S-Sale
截至 2026年6月9日
PTPI 季度内部人买卖趋势
PTPI 内幕交易卖出 · PTPI 内幕交易买入 · 季度活动
Mobile shows last 4Q · Desktop shows full 8Q
▸ 数据来源：SEC EDGAR · Form 3 & 4 · 最近8季度
As of Jun 9, 2026
活跃内部人
近12个月交易最活跃 · PTPI CEO内幕交易
显示全部内部人 · 点击卡片过滤下方交易表
▸ 按reportingName聚合 · 近12月交易次数Top5 · 无额外API
近期内幕交易记录
PTPI 高管卖出股份 · PTPI 董事内幕交易 · SEC Form 4申报
横向滑动查看全部列
| 日期 | 内部人 | 类型 | 股数 | 总金额 | 申报 |
|---|---|---|---|---|---|
| Jun 5, 2026 | WALKER WAYNE REMELL Director | Award | 375,000 | — | Form 4 |
| Jun 5, 2026 | Boctor Fady See Remarks | Award | 375,000 | — | Form 4 |
| Jun 5, 2026 | Bernstein Bruce Director | Award | 1,875,000 | — | Form 4 |
| Jun 5, 2026 | Silverman Joshua Director | Award | 4,375,000 | — | Form 4 |
| Jan 2, 2026 | Boctor Fady See Remarks | Award | 500,000 | — | Form 4 |
| Jan 2, 2026 | Silverman Joshua Director | Award | 4,375,000 | — | Form 4 |
| Jan 2, 2026 | WALKER WAYNE REMELL Director | Award | 500,000 | — | Form 4 |
| Jan 2, 2026 | Bernstein Bruce Director | Award | 1,875,000 | — | Form 4 |
| Feb 19, 2025 | WALKER WAYNE REMELL Director | Award | 150,000 | — | Form 4 |
| Feb 19, 2025 | Arnold Mitchell See Remarks | Award | 150,000 | — | Form 4 |
| Feb 19, 2025 | Silverman Joshua Director | Award | 1,000,000 | — | Form 4 |
| Feb 19, 2025 | Boctor Fady See Remarks | Award | 450,000 | — | Form 4 |
| Feb 19, 2025 | Bernstein Bruce Director | Award | 300,000 | — | Form 4 |
| Dec 21, 2023 | Boctor Fady See Remarks | Award | 49,645 | — | Form 4 |
| Apr 26, 2023 | Bradley Greg Director | Option | 6,050 | — | Form 4 |
| Apr 26, 2023 | Bernstein Bruce Director | Option | 6,050 | — | Form 4 |
| Apr 26, 2023 | WALKER WAYNE REMELL Director | Option | 6,050 | — | Form 4 |
| Apr 26, 2023 | Silverman Joshua Director | Option | 6,722 | — | Form 4 |
| Jan 20, 2023 | WALKER WAYNE REMELL Director | Option | 2,264 | — | Form 4 |
| Jan 20, 2023 | Silverman Joshua Director | Option | 2,515 | — | Form 4 |
| Jan 20, 2023 | Bradley Greg Director | Option | 2,264 | — | Form 4 |
| Jan 20, 2023 | Bernstein Bruce Director | Option | 2,264 | — | Form 4 |
▸ 数据来源：SEC EDGAR · Form 4 申报 · ⚡ = 金额≥$100万 · Award/Option 价格显示 —
关于 PTPI 内幕交易
PTPI 内幕交易
Petros Pharmaceuticals, Inc.（PTPI）内幕交易数据来源于公司内部人（包括WALKER WAYNE REMELL (Director), Boctor Fady (See Remarks), Bernstein Bruce (Director)）提交的SEC Form 4申报文件。过去12个月内，4位内部人向SEC提交了交易申报。PTPI内部人近期买卖活动混合，这可能反映预设的10b5-1计划执行，而非方向性判断。
如需查看Petros Pharmaceuticals, Inc.机构持仓比例和内部人持股百分比，请访问持仓（Ownership）标签页 → Ownership tab →
常见问题
PTPI 内幕交易 · 5个问题Petros Pharmaceuticals, Inc.（PTPI）的内部人包括高管和董事，如WALKER WAYNE REMELL (Director), Boctor Fady (See Remarks), Bernstein Bruce (Director)等。过去12个月内，4位内部人向SEC提交了Form 4交易申报。内部人须在交易日期后2个工作日内完成申报。
▸ 数据来源：FMP /stable/insider-trading/search · SEC EDGAR Form 3 & 4 · RSU归属不计入情绪 · As of Jun 9, 2026